tiprankstipranks
Trending News
More News >
Accendra Health (ACH)
NYSE:ACH

Accendra Health (ACH) Price & Analysis

Compare
551 Followers

ACH Stock Chart & Stats

Currently, no data available
Please return soon. This page is being updated.

ACH FAQ

What was Accendra Health’s price range in the past 12 months?
Accendra Health lowest stock price was $1.84 and its highest was $15.54 in the past 12 months.
    What is Accendra Health’s market cap?
    Accendra Health’s market cap is $166.30M.
      When is Accendra Health’s upcoming earnings report date?
      Accendra Health’s upcoming earnings report date is Feb 25, 2026 which is in 46 days.
        How were Accendra Health’s earnings last quarter?
        Accendra Health released its earnings results on Oct 30, 2025. The company reported $0.25 earnings per share for the quarter, beating the consensus estimate of $0.235 by $0.015.
          Is Accendra Health overvalued?
          According to Wall Street analysts Accendra Health’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Accendra Health pay dividends?
            Accendra Health does not currently pay dividends.
            What is Accendra Health’s EPS estimate?
            Accendra Health’s EPS estimate is 0.23.
              How many shares outstanding does Accendra Health have?
              Accendra Health has 77,346,596 shares outstanding.
                What happened to Accendra Health’s price movement after its last earnings report?
                Accendra Health reported an EPS of $0.25 in its last earnings report, beating expectations of $0.235. Following the earnings report the stock price went same N/A.
                  Which hedge fund is a major shareholder of Accendra Health?
                  Currently, no hedge funds are holding shares in ACH
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Company Description

                    Accendra Health

                    Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide. The company operates in two segments, Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, including supplier management, analytics, inventory management, and clinical supply management; and various programs to provide outsourced logistics and marketing solutions to its suppliers. The Patient Direct segment provides products and services for in-home care and delivery across diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment. This segment also supplies a range of other home medical equipment; and patient care products, including ostomy, wound care, urology, and incontinence and other products and services. The company serves multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. Accendra Health, Inc. was formerly known as Owens & Minor, Inc. and changed its name Accendra Health, Inc. in December 2025. The company was founded in 1882 and is based in Glen Allen, Virginia.

                    Accendra Health (ACH) Earnings & Revenues

                    ACH Company Deck

                    ACH Earnings Call

                    Q3 2025
                    0:00 / 0:00

                    ACH Stock 12 Month Forecast

                    Average Price Target

                    $3.50
                    ▲(48.31% Upside)
                    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

                    Ownership Overview

                    20.72%20.50%33.63%9.79%
                    20.72%
                    Insiders
                    20.50%
                    Mutual Funds
                    33.63% Other Institutional Investors
                    9.79% Public Companies and
                    Individual Investors

                    Options Prices

                    Currently, No data available
                    ---
                    Popular Stocks